Bicocca Open Archive

Logo unimib boa
COLLEDAN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.001
AS - Asia 17.088
EU - Europa 12.114
SA - Sud America 2.871
AF - Africa 400
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 30
Totale 52.538
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.367
SG - Singapore 6.344
HK - Hong Kong 3.626
IT - Italia 3.163
RU - Federazione Russa 2.619
CA - Canada 2.444
VN - Vietnam 2.394
CN - Cina 2.255
BR - Brasile 2.210
IE - Irlanda 1.663
DE - Germania 1.109
SE - Svezia 1.050
FR - Francia 700
BD - Bangladesh 554
GB - Regno Unito 475
IN - India 380
UA - Ucraina 306
KR - Corea 299
AR - Argentina 274
FI - Finlandia 218
ID - Indonesia 189
IQ - Iraq 182
ES - Italia 169
NL - Olanda 150
TR - Turchia 147
ZA - Sudafrica 126
PK - Pakistan 110
EC - Ecuador 103
AT - Austria 94
SA - Arabia Saudita 90
CO - Colombia 81
MX - Messico 80
JP - Giappone 79
VE - Venezuela 67
BE - Belgio 65
CH - Svizzera 62
PH - Filippine 60
UZ - Uzbekistan 55
PL - Polonia 54
EG - Egitto 51
KE - Kenya 45
DK - Danimarca 43
MA - Marocco 40
MY - Malesia 40
PY - Paraguay 40
CL - Cile 38
NP - Nepal 36
PE - Perù 32
JO - Giordania 30
DZ - Algeria 29
AE - Emirati Arabi Uniti 28
AU - Australia 28
PT - Portogallo 27
ET - Etiopia 26
JM - Giamaica 26
TN - Tunisia 25
CZ - Repubblica Ceca 23
EU - Europa 23
AZ - Azerbaigian 22
RO - Romania 22
LT - Lituania 18
PS - Palestinian Territory 18
UY - Uruguay 18
KZ - Kazakistan 17
CR - Costa Rica 16
OM - Oman 16
DO - Repubblica Dominicana 14
IR - Iran 13
RS - Serbia 13
AL - Albania 12
HN - Honduras 12
IL - Israele 12
SN - Senegal 12
PA - Panama 11
TH - Thailandia 11
TW - Taiwan 11
LB - Libano 10
LY - Libia 9
NI - Nicaragua 9
BG - Bulgaria 8
BH - Bahrain 8
GR - Grecia 8
KW - Kuwait 8
TT - Trinidad e Tobago 8
BO - Bolivia 7
KG - Kirghizistan 7
SK - Slovacchia (Repubblica Slovacca) 7
XK - ???statistics.table.value.countryCode.XK??? 7
AO - Angola 6
CI - Costa d'Avorio 6
NZ - Nuova Zelanda 6
HU - Ungheria 5
LV - Lettonia 5
MU - Mauritius 5
QA - Qatar 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
GE - Georgia 4
HR - Croazia 4
MM - Myanmar 4
Totale 52.466
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.580
Singapore 3.265
Toronto 2.286
Dublin 1.620
Ashburn 1.513
San Jose 1.308
Ann Arbor 1.253
Princeton 819
New York 816
Milan 765
Ho Chi Minh City 708
Fairfield 659
Frankfurt am Main 634
Chicago 628
Chandler 586
Hanoi 571
Santa Clara 547
The Dalles 545
Woodbridge 527
Dallas 507
Houston 432
Lawrence 385
Lauterbourg 378
Wilmington 357
Los Angeles 349
Altamura 339
Rome 329
Moscow 302
Seoul 278
Seattle 266
Beijing 258
Council Bluffs 233
Hefei 229
Cambridge 209
Jacksonville 192
São Paulo 177
Buffalo 164
San Diego 144
Helsinki 139
Shanghai 126
Andover 117
Dearborn 111
Da Nang 108
Jakarta 100
Haiphong 92
Nuremberg 90
London 86
Rio de Janeiro 84
Munich 79
Orem 79
Boardman 74
Baghdad 70
Turin 68
Guangzhou 64
Nanjing 63
Salt Lake City 63
Hangzhou 56
Johannesburg 55
Atlanta 52
Tokyo 52
Naples 49
Belo Horizonte 48
Figino 47
Biên Hòa 46
Brasília 46
Florence 46
Tashkent 46
Hải Dương 44
Curitiba 43
Denver 43
Montreal 43
Boston 41
Brooklyn 40
San Francisco 40
Vienna 40
Amsterdam 39
Brussels 39
Bologna 38
Dhaka 36
Nairobi 36
Riyadh 36
Lahore 35
Manchester 35
Norwalk 35
Quito 35
Chennai 34
Tukwila 33
Campinas 32
Changsha 31
Istanbul 31
Phoenix 31
Quận Bình Thạnh 31
Lachine 30
Porto Alegre 30
Thái Nguyên 30
Warsaw 30
Pune 29
Guayaquil 28
Ha Long 27
Miami 27
Totale 31.466
Salva come PNG Salva come JPEG
Nome #
A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation 749
Reply to: “Outcome of in situ split liver transplantation in Italy over the last 25 years: An alternative analysis and personal view” 500
Recipient hepatectomy technique may affect oncological outcomes of liver transplantation for hepatocellular carcinoma 492
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 458
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 398
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 388
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 382
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 364
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 360
Health related quality of life in chronic liver diseases 340
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 323
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 315
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 314
Multicentre evaluation of case volume in minimally invasive hepatectomy 301
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 289
Delaying surgery for patients with a previous SARS-CoV-2 infection 289
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 286
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 284
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 282
Reno-portal bypass for non tumorous portal vein thrombosis in adult liver transplantation 277
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 273
Health Related Quality of Life in the Major Liver Conditions 270
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 268
COVID-19: role of resilience on the psychological impact of lockdown in liver transplant transitional candidates and recipients COVID-19: ruolo della resilienza sull’impatto psicologico del lockdown nei candidati e nei riceventi del trapianto di fegato (adolescenti-giovani adulti) 264
The impact of the COVID-19 outbreak on liver transplantation programs in Northern Italy 263
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 256
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 251
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients 250
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list 250
Treatment of hepatocellular carcinoma: A cost analysis of yttrium-90 transarterial radioembolization versus sorafenib 245
Balancing donor and recipient risk factors in liver transplantation: The value of D-MELD with particular reference to HCV recipients 242
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 242
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs 241
Combined double lung-liver transplantation for cystic fibrosis without cardio-pulmonary by-pass. 239
Biliary complications in pediatric liver transplantation: findings of percutaneous transhepatic cholangiography in a large single-center cohort 237
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 236
Post-operative heparin reduces early venous thrombotic complications after orthotopic paediatric liver transplantation 235
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 232
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: Results from a 7-year experience 231
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study 231
Technical and Clinical Outcomes of Laparoscopic–Laparotomic Hepatocellular Carcinoma Thermal Ablation with Microwave Technology: Case Series and Review of Literature 228
Arterioportal fistulas (Apfs) in pediatric patients: Single center experience with interventional radiological versus conservative management and clinical outcomes 227
Extended right split liver graft for primary transplantation in children and adults. 225
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria 222
Selective use of ex-situ machine perfusion after normothermic regional perfusion in liver transplantation from donation after circulatory death 222
The Role of Imaging in Portal Vein Thrombosis: From the Diagnosis to the Interventional Radiological Management 220
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry 220
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry 220
Portal vein thrombosis and liver transplantation: management, matching, and outcomes: a retrospective multicenter cohort study 219
Early detection of the graft failure after pediatric liver transplantation: a Bergamo experience 218
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 218
Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient 215
Current Endovascular Management of Arterial Complications After Pediatric Liver Transplantation in a Tertiary Center 214
Trapianto intestinale 210
Venous outflow obstruction in pediatric left lateral segment split liver transplantation 209
Nuclear expression of s100a4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization 209
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma 203
Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection 203
Living Donor Lung Transplantation After Hematopoietic Stem Cell Transplantation From the Same Donor: A Risk Worth Taking 201
Use of extended right grafts from in situ split livers in adult liver transplantation: a comparison with whole-liver transplants. 200
Full-right-full-left split liver transplantation: The retrospective analysis of an early multicenter experience including graft sharing 198
Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus 195
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool 193
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 192
Extended criteria liver donation after circulatory death with prolonged warm ischemia: a pilot experience of normothermic regional perfusion and no subsequent ex-situ machine perfusion 191
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 185
Successful Lung Transplantation From a Donor With Previous Severe COVID-19 Pneumonia 184
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation 182
Liver transplants in children: The 8 years experience in Bergamo 181
Exploring auxiliary liver transplantation in the era of transplant oncology - A proposal for a new liver splitting program (ALERT-50) 180
A prospective policy development to increase split-liver transplantation for 2 adult recipients: Results of a 12-year multicenter collaborative study 179
Very Early Introduction of Everolimus in De Novo Liver Transplantation: Results of a Multicenter, Prospective, Randomized Trial 179
Physiological reno-portal bypass in liver transplantation with non-tumorous portal vein thrombosis 178
Improving outcomes of in situ split liver transplantation in Italy over the last 25 years 178
Early post-liver transplant surgical morbidity in HIV-infected recipients: risk factor for overall survival? A nationwide retrospective study 177
Correction to: Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry (Updates in Surgery, (2017), 69, 3, (271-283), 10.1007/s13304-017-0489-x) 176
Improving Outcome of Selected Patients With Non-Resectable Hepatic Metastases From Colorectal Cancer With Liver Transplantation: A Prospective Parallel Trial (COLT trial) 173
A national mandatory-split liver policy: A report from the Italian experience 173
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 169
Liver transplantation for hepatocellular carcinoma: Bergamo experience 169
A matched pair analysis of multicenter longterm follow-up after split-liver transplantation with extended right grafts 168
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial 167
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 163
Evidence for biliary epithelial to mesenchymal transition in human cholangiocarcinoma 163
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 162
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 161
Location and allocation: inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe 161
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 159
Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma 157
Transitional care in pediatric liver transplantation: do we need to structure a personalized program? 157
EVIDENCE FOR EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA 154
Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry 153
Indications and successes of intestinal transplantation in children in the 21st century: A retrospective cohort study 152
Liver Perfusion in Multiorgan Harvesting for Transplantation 151
Prolonged and repeated courses of OKT3 after liver transplantation 149
D-MELD, a Powerful Instrument To Optimize Donor-2-Recipient Match. Differences between US and Italy 149
The Activity of the Liver-Transplant Center of Milan, Italy 145
Patterns of hepatitis delta virus reinfection and disease in liver transplantation 144
Liver transplantation in patients with B viral hepatitis and delta infection 144
Results of 24 orthotopic liver transplantation in Milan 143
Totale 23.384
Salva come PNG Salva come JPEG
Categoria #
all - tutte 234.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.193
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021128 0 0 0 0 0 0 0 0 0 0 0 128
2021/20223.535 67 81 172 585 183 192 63 206 90 969 155 772
2022/20234.576 815 1.320 379 209 212 860 54 183 248 84 148 64
2023/20244.548 76 98 164 160 682 1.142 894 139 549 66 78 500
2024/202511.943 647 1.854 488 490 1.059 272 500 338 1.693 1.843 923 1.836
2025/202624.969 2.585 1.831 1.771 2.120 1.973 1.183 3.220 1.223 1.760 1.818 3.244 2.241
Totale 53.980